Prediction of Outcomes After Surgery for Unruptured Intracranial Aneurysms
Trial ID or NCT#
Status
Purpose
Accurate preoperative identification of patients at high risk for adverse outcomes would be clinically advantageous, as it would allow enhanced resource preparation, better surgical decision-making, enhanced patient education and informed consent, and potentially even modification of certain modifiable risk factors. The aim of the Prediction of adverse events after microsurgery for intracranial unruptured aneurysms (PRAEMIUM) study is therefore to develop and externally validate a clinically applicable, robust ML-based prediction tool based on multicenter data from a range of international centers.
Official Title
The Prediction of Adverse Events After Microsurgery for Intracranial Unruptured Aneurysms (PRAEMIUM) Study
Eligibility Criteria
- * Adult patients (18 or older)* Undergone microsurgical treatment for unruptured intracranial aneurysm* Patients with prior SAH may only be included when surgical treatment occurred at least 4 weeks after ictus.* Treated from January 1st 2010 onwards
- * No specific exclusion criteria
Investigator(s)
Contact us to find out if this trial is right for you.
Contact
Gary K Steinberg
View on ClinicalTrials.gov